In turn, IL-2 may be responsible for the increased plasma IL-5 in our allergic subjects [49], and successful oral immunotherapy for peanut allergy is associated with a decrease in both IL-5 and IL-2 [50]. Here, IL5 is linked to peanut allergic reaction.